Dr Marit van Elsas
Honorary (Fellow)
The Sir Peter MacCallum Department of Oncology
16 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
ENHANCING CHIMERIC ANTIGEN RECEPTOR (CAR) T CELL THERAPY FOR PAEDIATRIC SARCOMA THROUGH CAR T ENGINEERING AND TUMOUR MICROENVIRONMENT REWIRING
DOI: 10.1016/j.jcyt.2026.1022252025
Journal article
Tumor site-directed A1R expression enhances CAR T cell function and improves efficacy against solid tumors
DOI: 10.1038/s41467-025-59021-92025
Journal article
Transcriptional regulator SATB1 limits CD8 T cell population expansion and effector differentiation in chronic infection and cancer
DOI: 10.1038/s41590-025-02316-22025
Journal article
Rewiring endogenous genes in CAR T cells for tumour-restricted payload delivery
DOI: 10.1038/s41586-025-09212-72024
Journal article
Myeloid effector cells in cancer
DOI: 10.1016/j.ccell.2024.11.0022024
Journal article
Immunotherapy-activated T cells recruit and skew late-stage activated M1-like macrophages that are critical for therapeutic efficacy
DOI: 10.1016/j.ccell.2024.04.0112023
Journal article
PD-L1 checkpoint blockade promotes regulatory T cell activity that underlies therapy resistance
DOI: 10.1126/sciimmunol.abn6173
RECENT SCHOLARLY WORKS
2023
Journal article
Invasive margin tissue-resident macrophages of high CD163 expression impede responses to T cell-based immunotherapy
DOI: 10.1136/jitc-2022-0064332022
Journal article
Regulatory T Cell Depletion Using a CRISPR Fc-Optimized CD25 Antibody
DOI: 10.3390/ijms231587072022
Journal article
NKG2A is a late immune checkpoint on CD8 T cells and marks repeated stimulation and cell division
DOI: 10.1002/ijc.33859